ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis	eye disorder, retinal degeneration, retinal disorder, retinoschisis	Recruiting	Phase 3	2026-09-29		NCT05878860

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Atsena Therapeutics Inc.	2

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Associated Retina Consultants	Phoenix	United States	21
Bascom Palmer Eye Institute	Miami	United States	17
Boston Children's Hospital	Boston	United States	343
Children's Hospital of Los Angeles	Los Angeles	United States	56
Children's Hospital of Philadelphia	Philadelphia	United States	434
Columbia University	New York	United States	1
Duke University	Durham	United States	160
Flaum Eye Institute, University of Rochester	Rochester	United States	1
Massachusetts Eye and Ear	Boston	United States	21
Mayo Clinic	Rochester	United States	664
McGill University (MUHC)	Montreal	Canada	1
Moran Eye Center	Salt Lake City	United States	1
Oregon Health Sciences University	Portland	United States	33
Oxford Eye Hospital	Oxford	United Kingdom	1
Retina Foundation of the Southwest	Dallas	United States	38
Shiley Eye Institute	La Jolla	United States	1
Stanford University	Palo Alto	United States	11
The Hospital for Sick Children	Toronto	Canada	4
UC San Francisco	San Francisco	United States	2
University of Michigan	Ann Arbor	United States	18
University of Wisconsin	Madison	United States	64

Clinical trials